Collectively, these data indicate that the CD44/CD24 marker combination does not enable consistent identification of a unique population of highly tumorigenic cells in salivary gland mucoepidermoid carcinomas. Here, CD44 is linked to salivary gland mucoepidermoid carcinoma.